We are live on ! Find out more
ERNA icon

Eterna Therapeutics

7 hedge funds and large institutions have $4.47M invested in Eterna Therapeutics in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 77 (0)

41% less capital invested

Capital invested by funds: $7.63M → $4.47M (-$3.16M)

Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
+$259K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6K

ERNA Hedge Fund Activity: Q2 2015 in Review

7 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2015, worth a combined $4.47M — down 41% from $7.63M a quarter earlier.

Fund positioning in ERNA was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was AWM Investment Company, adding an estimated $259K. The largest seller was Susquehanna International Group, cutting an estimated $6K.

  • 7 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $4.47M of Eterna Therapeutics stock for Q2 2015, down 41% quarter-over-quarter.
  • 0 funds opened new Eterna Therapeutics positions in Q2 2015 and 0 closed out.
  • The largest Eterna Therapeutics buyer in Q2 2015 was AWM Investment Company, an estimated $259K added.
  • The largest Eterna Therapeutics seller in Q2 2015 was Susquehanna International Group, an estimated $6K sold.

Based on aggregated 13F filings for Q2 2015.